Using the microbiome to combat lung pathogens

Adam Arkin, professor of bioengineering at UC Berkeley, is spearheading a groundbreaking research effort to harness the lung microbiome as a new way to combat deadly bacterial infections without relying on traditional antibiotics. The multidisciplinary team is developing probiotic and prebiotic combinations that empower beneficial lung bacteria to outcompete harmful pathogens. Dr. Arkin describes the approach as having the potential to transform how we prevent and treat antimicrobial-resistant diseases in the future. Read more about the study here.